News

Novavax reports strong immune responses from H5N1 avian flu vaccine candidate, showing promise in single and two-dose ...
The H5N1 bird flu virus has historically extracted a heavy toll when it infects humans, with nearly half of confirmed cases ...
Novavax, Inc. (NVAX) on Thursday announced preclinical data demonstrating that the company’s H5N1 bird flu vaccine candidate induced robust immune responses in nonhuman primates. H5N1 is a highly ...
The bird flu hit Susie’s Duck Sanctuary in Wahiawa hard, and hundreds of ducks, geese, and other birds had to be euthanized ...
The fatality rate for H5N1 highly pathogenic avian influenza in humans has historically been high, with more than half of ...
Canada does not currently have a bird flu vaccine, but research is underway at the University of Guelph to try and create an ...